Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FQ62X
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 80 mg tablets (60-count units). This firm fixed-price delivery order, issued on July 1, 2025, with an ultimate completion date of July 2, 2025, represents a time-sensitive pharmaceutical supply requirement. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its small business status. Performance will be completed at the company's facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites, with a robust portfolio covering branded and generic prescription medications, biologics, and medical consumables across oncology treatments and other therapeutic categories.
Quick answers
Who was awarded contract SPE2DB25FQ62X?
SPE2DB25FQ62X was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 1, 2025.
How much is contract SPE2DB25FQ62X worth?
The government has obligated $4,170 on SPE2DB25FQ62X.
Is contract SPE2DB25FQ62X an order under another contract?
Yes. SPE2DB25FQ62X is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB25FQ62X competed?
The extent of competition for SPE2DB25FQ62X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award